Abb Vie Hero

Hep C and Humira lead AbbVie's Q1 revenue growth

April 26, 2018 • 4 min read

AbbVie posted better than expected Q1 earnings this morning, led by HUMIRA, IMBRUVICA and their Hepatitis C franchise. Total worldwide revenue was $7.934 billion, helping AbbVie achieve YOY growth of 17.4% in the quarter.  AbbVie's heavily weighted revenue from HUMIRA is concerning and yet impressive, considering 2/3 of the companies revenue comes from the product. Where the concern lessens is from the continued growth in HCV, where their franchise exploded to $919 million in revenue,...

Continue reading

Bsc Core Hero

Diversified growth lifts Boston Scientific in Q1

April 25, 2018 • 4 min read

Boston Scientific reported 2018 Q1 earnings this morning, posting sales of $2.379 billion, growing operationally 10.1% with organic growth of 5.2%, compared to prior year growth in the same quarter. Additionally, the company raised FY 2018 guidance, now...

Continue reading

Philips Hero

Philips posts solid start to 2018

April 23, 2018 • 3 min read

Philips released Q1 earnings this morning and posted solid results to start off 2018.Sales in the quarter were EUR 3.9 billion, with comparable sales growth of 5% Comparable order intake increased 10% compared to Q1 2017...

Continue reading

Mazor Hero

Mazor Robotics Q1 2018 Investor Presentation

April 18, 2018 • 2 min read

The following Q1 2018 investor presentation was published by Mazor Robotics. Mazor is expected to release earnings on or before May 9, 2018. We will be covering their earnings release. ...

Continue reading

Screen Shot 2018 04 17 At 6 30 35 Pm

Intuitive Surgical hits 2018 priorities. Blows past Q1 expectations

April 18, 2018 • 3 min read

Shares of Intuitive Surgical are up ~5% in early morning trading after crushing their latest Q1 earnings numbers. Intuitive Surgical CEO, Gary Guthart, laid out specific priorities for the company at the beginning of 2018, and based on those set metrics...

Continue reading

Orthopedics Total Hip Step1

Johnson & Johnson medical device business delivers 7.5% growth in Q1

April 17, 2018 • 3 min read

Johnson & Johnson announced Q1 earnings this morning and came through with a relatively strong performance in their medical device segment, growing ~7.5% for the quarter. However, according to their earnings presentation, when you factor sales excluding...

Continue reading

Bsc Womens Health Hero

Boston Scientific Acquires nVision Medical

April 16, 2018 • 3 min read

Boston Scientific announced the acquisition of nVision Medical, who developed the first and only device cleared by the U.S. Food and Drug Administration to collect cells from the fallopian tubes, offering a potential platform for earlier diagnosis of...

Continue reading

Bscfocus

Boston Scientific marketing gets innovative with new video series

April 13, 2018 • 3 min read

Marketing in the medical device industry has always felt limited. Companies are usually limited on what they share via social media over regulatory concerns, although this is slowly changing. Slowly. ...

Continue reading

Jnjcontacts

J&J Vision Announces Revolutionary Transitional Contact Lens

April 11, 2018 • 3 min read

Johnson & Johnson Vision just announced one of the more exciting new contact lens products to hit the market in years. They partnered with Transition Optical, the leading provider of photochromic (smart adaptive) lenses and came up with the ACUVUE OASYS...

Continue reading

Next Page